Elisabet Cuyàs Navarro
机构: Girona Biomedical Research Institute (IDIBGi)
每年引用次数
引用次数
引用: 4,216
H-指数: 39
I10-指数 : 81
出版物: 139
Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient
Bruna Corominas-Faja , Begoña Martin-Castillo , Joaquim Bosch-Barrera , Javier A. Menendez
Anticancer Research 34 ( 8) 4323 -4327
16
2014
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
Bruna Corominas-Faja , Javier A. Menendez , Luciano Vellon , Jordi García
Histology and Histopathology 32 ( 7) 687 -698
61
2017
Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology.
Begoña Martin-Castillo , Javier A Menendez , Elisabet Cuyàs , Sara Verdura
Frontiers in Oncology 10 620641
2021
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
Travis Vander Steen , Ingrid Espinoza , Javier A Menendez , Luciano Vellon
Cancers 13 ( 5) 1132
2021
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
Pilar Blancafort , Charlene Waryah , Charlene Waryah , Bartosz Wasag
Nature Communications 12 ( 1) 1920 -1920
12
2021
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells
Sílvia Cufí , Rosa Bonavia , Alejandro Vazquez-Martin , Bruna Corominas-Faja
Food and Chemical Toxicology 60 360 -368
33
2013
Silibinin is a direct inhibitor of STAT3.
Sara Verdura , Elisabet Cuyàs , Laura Llorach-Parés , Almudena Pérez-Sánchez
Food and Chemical Toxicology 116 161 -172
24
2018
Epigenetics and nutrition-related epidemics of metabolic diseases: Current perspectives and challenges.
Anna Hernández-Aguilera , Salvador Fernández-Arroyo , Elisabet Cuyàs , Fedra Luciano-Mateo
Food and Chemical Toxicology 96 191 -204
19
2016
Active transmembrane drug transport in microgravity: a validation study using an ABC transporter model
Sergi Vaquer , Elisabet Cuyàs , Arnau Rabadán , Albert González
F1000Research 3 201 -201
6
2014
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.
Sara Verdura , Elisabet Cuyàs , Eric Cortada , Joan Brunet
Verdura, Sara Cuyàs, Elisabet Cortada, Eric Brunet i Vidal, Joan López Bonet, Eugeni Martin Castillo, Begoña Bosch Barrera, Joaquim Encinar, José Antonio Menéndez Menéndez, Javier Abel 2020 Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity. Aging-Us 12 ( 1) 8 -34
84
2020
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.
Elisabet Cuyàs , Juan Gumuzio , Sara Verdura , Joan Brunet
Aging 12 ( 6) 4794 -4814
36
2020
Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity.
Elisabet Cuyàs , Juan Gumuzio , Jesús Lozano-Sánchez , Antonio Segura-Carretero
Aging 12 ( 21) 21057 -21075
2020
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.
Elisabet Cuyàs , Salvador Fernández-Arroyo , Maria Buxó , Sonia Pernas
Aging (Albany NY) 11 ( 9) 2874 -2888
10
2019
In silico clinical trials for anti-aging therapies.
Javier A. Menendez , Elisabet Cuyàs , Núria Folguera-Blasco , Sara Verdura
Aging (Albany NY) 11 ( 16) 6591 -6601
2
2019
Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas
Begoña Martin-Castillo , Eugeni Lopez-Bonet , Elisabet Cuyàs , Gemma Viñas
Oncotarget 6 ( 32) 32317 -32338
14
2015
The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
Elisabet Cuyàs , Antonio Verdejo-García , Ana Beatriz Fagundo , Olha Khymenets
PLoS ONE 6 ( 11) e27206
34
2011
Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion.
Ximena Perfetti , Brian O'Mathúna , Nieves Pizarro , Elisabet Cuyàs
Drug Metabolism and Disposition 37 ( 7) 1448 -1455
32
2009
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.
Elisabet Cuyàs , Bruna Corominas-Faja , María Muñoz-San Martín , Begoña Martin-Castillo
Oncotarget 8 ( 21) 35019 -35032
8
2017
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Ricardo Pardo-Lozano , Magí Farré , Samanta Yubero-Lahoz , Brian O’Mathúna
PLoS ONE 7 ( 10) e47599 -10
45
2012
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users
Ana B Fagundo , Elisabet Cuyàs , Antonio Verdejo-Garcia , Olha Khymenets
Journal of Psychopharmacology 24 ( 9) 1381 -1393
14
2010